epigallocatechin gallate has been researched along with Allodynia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benov, L; Khan, KM; Renno, WM | 1 |
| Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B | 1 |
| Morgado, C; Pereira-Terra, P; Raposo, D; Tavares, I | 1 |
| Alberch, J; Boadas-Vaello, P; Puig, T; Turrado, C; Verdú, E; Vidal-Sancho, L; Xifró, X | 1 |
| Álvarez-Pérez, B; Boadas-Vaello, P; Bosch-Mola, M; Homs, J; Puig, T; Reina, F; Verdú, E | 2 |
| Chopra, K; Kuhad, A; Sachdeva, AK; Tiwari, V | 1 |
| Chopra, K; Kuhad, A; Tiwari, V | 1 |
| Chopra, K; Kuhad, A; Sachdeva, AK | 1 |
| Choi, JI; Kim, WM; Kim, YO; Lee, HG; Yoon, MH | 1 |
| Al-Banaw, A; Al-Maghrebi, M; Renno, WM | 1 |
11 other study(ies) available for epigallocatechin gallate and Allodynia
| Article | Year |
|---|---|
Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.
Topics: Animals; Antioxidants; Axons; Catechin; Crush Injuries; Disease Models, Animal; Hyperalgesia; Male; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Oxidative Stress; Peripheral Nerve Injuries; Random Allocation; Rats, Wistar; Recovery of Function; RNA, Messenger; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord | 2017 |
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.
Topics: Adenomyosis; Animals; Biomarkers; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrocortisone; Hyperalgesia; Mice; Mice, Inbred ICR; Myometrium; Pain Threshold; Reaction Time; Stress, Physiological; Tamoxifen; Time Factors; Uterine Contraction | 2013 |
Nociceptive spinal cord neurons of laminae I-III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG).
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Catechin; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Immunohistochemistry; Male; Neuralgia; Neuroprotective Agents; Nociceptors; Oxidative Stress; Proto-Oncogene Proteins c-fos; Rats, Wistar; Spinal Cord; Touch | 2015 |
Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.
Topics: Animals; Catechin; Cell Membrane; Cytokines; Fatty Acid Synthase, Type I; Fatty Acids; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neuralgia; Pain; Pain Threshold; Peripheral Nerve Injuries; Spinal Cord Injuries | 2015 |
Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice.
Topics: Animals; Catechin; Contusions; Down-Regulation; Female; Hyperalgesia; Locomotion; Mice; Mice, Inbred BALB C; Nerve Fibers; Nociceptors; Pain Measurement; Recovery of Function; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Spinal Cord; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2016 |
(-)-Epigallocatechin-3-Gallate Antihyperalgesic Effect Associates With Reduced CX3CL1 Chemokine Expression in Spinal Cord.
Topics: Animals; Catechin; Chemokine CX3CL1; Female; Hyperalgesia; Mice; Mice, Inbred BALB C; Spinal Cord | 2017 |
Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence.
Topics: Animals; Antioxidants; Brucella abortus; Catalase; Catechin; Disease Models, Animal; Fatigue Syndrome, Chronic; Glutathione; Hyperalgesia; Lipid Peroxidation; Lipopolysaccharides; Locomotion; Mice; Mice, Inbred Strains; Nitrites; Oxidative Stress; Superoxide Dismutase; Swimming; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2009 |
Amelioration of functional, biochemical and molecular deficits by epigallocatechin gallate in experimental model of alcoholic neuropathy.
Topics: Alcoholic Neuropathy; Analysis of Variance; Animals; Behavior, Animal; Catechin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hyperalgesia; Male; Oxidative Stress; Physical Stimulation; Rats; Rats, Wistar; Urokinase-Type Plasminogen Activator | 2011 |
Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome.
Topics: Animals; Behavior, Animal; Body Weight; Brain Chemistry; Catechin; Cognition; Drinking; Eating; Fatigue Syndrome, Chronic; Hyperalgesia; Male; Maze Learning; Motor Activity; Nitric Oxide; Organ Size; Oxidative Stress; Physical Endurance; Postural Balance; Psychomotor Performance; Rats; Rats, Wistar; Stress, Psychological; Tumor Necrosis Factor-alpha | 2011 |
Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model.
Topics: Animals; Arginine; Catechin; Disease Models, Animal; Extremities; Hyperalgesia; Injections, Spinal; Ligation; Male; Neuralgia; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves | 2012 |
(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Behavior, Animal; Catechin; Desmin; Foot; Hot Temperature; Hyperalgesia; Immunohistochemistry; Male; Muscle, Skeletal; Nerve Crush; Neuroprotective Agents; Pain Measurement; Posture; Rats; Rats, Wistar; Reaction Time; Real-Time Polymerase Chain Reaction; Recovery of Function; RNA; Sciatic Neuropathy; Signal Transduction; Toes | 2012 |